Mizuho analyst Graig Suvannavejh raised the firm’s price target on Immatics (IMTX) to $19 from $16 and keeps an Outperform rating on the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMTX:
- Immatics Appoints Amie Krause as Chief People Officer Amidst Commercial Transition
- Immatics appoints Krause as Chief People Officer
- Immatics’ Promising Efficacy and Strategic Positioning Support Buy Rating
- Immatics Reports Promising Anzu-cel Results in Uveal Melanoma
- Immatics highlights anti-tumor activity of anzu-cel PRAME cell therapy